AR and breast cancer: Binding of Foxa1 to its targets was shown to be required for chromatin-association of androgen receptor (AR) in prostate cancer cells [27], and the estrogen receptor (ER) and retinoic acid receptor (RAR), in breast cancer cell lines [34], [46].